Effect of velmanase alfa (human recombinant alpha-mannosidase) enzyme-replacement therapy on quality of life and disease burden of patients with alpha-mannosidosis: Results from caregiver feedback

Allan Lund, Nathalie Guffon, Mercedes Gil-Campos, Frederica Cattaneo, Benedicte Heron, Anna Tylki-Szymanska, Line Borgwardt, Luc Regal, Duncan Cole, Julia Hennermann

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Pages (from-to)S67-S67
JournalMolecular Genetics and Metabolism
Volume132
Issue number2
DOIs
Publication statusPublished - Feb 2021
Event17th Annual Research Meeting of the We're-Organizing-Research-for-Lysosomal-Diseases-Symposium (WORLDS Symposium) (Online) -
Duration: 7 Feb 202112 Feb 2021

Cite this